Single-cell RNA sequencing has supplied cell atlases and artificial intelligence (AI)-enabled virtual-cell models with scalable, gene-level descriptions of cellular state. Yet prevalent poly(A)-based counting assays capture only part of the RNA landscape. Here, “single-cell whole-transcriptome detection” denotes sequencing-based efforts to detect a broader range of RNA biotypes than conventional poly(A)-based gene counting; no assay detects or quantifies every cellular RNA species without bias. We compare RNA-capture scope, transcript-structure resolution, temporal labeling, spatial context, and additional modalities as distinct measurement dimensions. From a biosensing perspective, analytical sensitivity, transcript coverage, throughput, and assay bias determine which signals are available to computational models. We then examine cell-state representations, regulatory networks, dynamics, perturbation prediction, and foundation models. Total-RNA assays reveal additional non-coding RNAs, long-read methods inform transcript structure, and temporal assays constrain RNA kinetics. Whether these signals improve prediction beyond conventional gene-count inputs requires matched, task-specific model comparisons. We distinguish molecular observability, statistical association, predictive performance, and causal validation, which requires appropriate interventions. We propose benchmarks controlling sequencing depth, cost, model architecture, and held-out samples while testing feature ablations, out-of-distribution performance, uncertainty calibration, and experimental outcomes. Together, high-throughput poly(A)-based profiling and broader RNA measurements provide complementary cellular breadth and regulatory depth.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: